Andre Wyss is US Country Head, President of Novartis Corporation & President of Novartis Pharmaceuticals Corporation (NPC). He joined NPC as President NPC and Head of US GenMeds in April 2010. In November 2012, his role was expanded to include President of Novartis Corporation, as well as cross-divisional coordination as the US Country Head. He is also a member of the Global Pharma Executive Committee.
Andre brings to this role proven leadership and strong experience gained from more than 28 years with the Novartis Group. Before coming to the US, Andre served as Head of Pharma Region Asia-Pacific, Middle East and African Countries (AMAC). Prior to that, he served as Head of Group Emerging Markets (GEM), where he significantly grew the presence of Novartis across all divisions in small emerging markets. Before leading GEM, Andre served as Country President and Head of Pharma, Greece, where he received the 2007 Novartis Business Excellence award.
During his career at Novartis, Andre served in leadership roles in Marketing and Sales, in both Primary Care and Specialty areas, R&D, Manufacturing and Finance around the world.